Oxford Endovascular secures £8 million to take novel brain aneurysm tech to human trials
/
DateMay 20 2024
Parkwalk Advisors led the latest funding round investing £4.2 million alongside Norcliffe Capital, The University of Oxford, Oxford Science Enterprises (OSE) and Vulpes Investment Management.... Read More →